Your browser doesn't support javascript.
loading
Outcomes after double switching from originator Infliximab to biosimilar CT-P13 and biosimilar SB2 in patients with inflammatory bowel disease: a 12-month prospective cohort study.
Trystram, Noémie; Abitbol, Vered; Tannoury, Jenny; Lecomte, Mahaut; Assaraf, Julie; Malamut, Georgia; Gagnière, Charlotte; Barré, Amélie; Sobhani, Iradj; Chaussade, Stanislas; Amiot, Aurélien.
Afiliación
  • Trystram N; Department of Gastroenterology, Henri Mondor Hospital, AP-HP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.
  • Abitbol V; Department of Gastroenterology, Cochin Hospital, AP-HP and University of Paris, Paris, France.
  • Tannoury J; Department of Gastroenterology, Henri Mondor Hospital, AP-HP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.
  • Lecomte M; Department of Digestive Surgery, Cochin Hospital, AP-HP and University of Paris, Paris, France.
  • Assaraf J; Department of Gastroenterology, Henri Mondor Hospital, AP-HP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.
  • Malamut G; Department of Gastroenterology, Cochin Hospital, AP-HP and University of Paris, Paris, France.
  • Gagnière C; Department of Gastroenterology, Henri Mondor Hospital, AP-HP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.
  • Barré A; Department of Gastroenterology, Cochin Hospital, AP-HP and University of Paris, Paris, France.
  • Sobhani I; Department of Gastroenterology, Henri Mondor Hospital, AP-HP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.
  • Chaussade S; Department of Gastroenterology, Cochin Hospital, AP-HP and University of Paris, Paris, France.
  • Amiot A; Department of Gastroenterology, Henri Mondor Hospital, AP-HP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.
Aliment Pharmacol Ther ; 53(8): 887-899, 2021 04.
Article en En | MEDLINE | ID: mdl-33647174

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Biosimilares Farmacéuticos Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Biosimilares Farmacéuticos Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Francia